» Articles » PMID: 20101764

Endoscope-guided Pneumatic Dilation for Treatment of Esophageal Achalasia

Overview
Specialty Gastroenterology
Date 2010 Jan 27
PMID 20101764
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Pneumatic dilation (PD) is considered to be the first line nonsurgical therapy for achalasia. The principle of the procedure is to weaken the lower esophageal sphincter by tearing its muscle fibers by generating radial force. The endoscope-guided procedure is done without fluoroscopic control. Clinicians usually use a low-compliance balloon such as Rigiflex dilator to perform endoscope-guided PD for the treatment of esophageal achalasia. It has the advantage of determining mucosal injury during the dilation process, so that a repeat endoscopy is not needed to assess the mucosal tearing. Previous studies have shown that endoscope-guided PD is an efficient and safe nonsurgical therapy with results that compare well with other treatment modalities. Although the results may be promising, long-term follow-up is required in the near future.

Citing Articles

Clinical and financial outcomes of per-oral endoscopic myotomy compared to laparoscopic heller myotomy for treatment of achalasia.

Shally L, Saeed K, Berglund D, Dudash M, Frank K, Obradovic V Surg Endosc. 2022; 37(7):5526-5537.

PMID: 36220985 DOI: 10.1007/s00464-022-09652-6.


A young lady with dysphagia.

Cheo S, Mak W, Low Q Malays Fam Physician. 2021; 16(2):98-101.

PMID: 34386174 PMC: 8346763. DOI: 10.51866/tyk1120.


Updated Systematic Review of Achalasia, with a Focus on POEM Therapy.

Cappell M, Stavropoulos S, Friedel D Dig Dis Sci. 2019; 65(1):38-65.

PMID: 31451984 DOI: 10.1007/s10620-019-05784-3.


Impact of preoperative balloon dilatation on outcomes of laparoscopic surgery in young patients with esophageal achalasia.

Tsuboi K, Omura N, Yano F, Hoshino M, Yamamoto S, Akimoto S Esophagus. 2018; 15(1):39-46.

PMID: 29892807 DOI: 10.1007/s10388-017-0593-5.


Gentamicin submucosal lavage during peroral endoscopic myotomy (POEM): a retrospective analysis.

Bayer J, Vackova Z, Svecova H, Stirand P, Spicak J, Martinek J Surg Endosc. 2017; 32(1):300-306.

PMID: 28656335 DOI: 10.1007/s00464-017-5677-8.


References
1.
Tutuian R, Castell D, Katz P . Pneumatic dilatations for achalasia: a safe and effective choice for most patients. Am J Gastroenterol. 2006; 101(10):2441-2. DOI: 10.1111/j.1572-0241.2006.00742_9.x. View

2.
Pasricha P, Ravich W, HENDRIX T, Sostre S, Jones B, Kalloo A . Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med. 1995; 332(12):774-8. DOI: 10.1056/NEJM199503233321203. View

3.
de Oliveira J, Birgisson S, Doinoff C, Einstein D, Herts B, Davros W . Timed barium swallow: a simple technique for evaluating esophageal emptying in patients with achalasia. AJR Am J Roentgenol. 1997; 169(2):473-9. DOI: 10.2214/ajr.169.2.9242756. View

4.
Ghoshal U, Kumar S, Saraswat V, Aggarwal R, Misra A, Choudhuri G . Long-term follow-up after pneumatic dilation for achalasia cardia: factors associated with treatment failure and recurrence. Am J Gastroenterol. 2004; 99(12):2304-10. DOI: 10.1111/j.1572-0241.2004.40099.x. View

5.
Richter J . Update on the management of achalasia: balloons, surgery and drugs. Expert Rev Gastroenterol Hepatol. 2008; 2(3):435-45. DOI: 10.1586/17474124.2.3.435. View